Abstract
This short review describes the main biomarkers used in research and clinical practice for colon cancer. There are several categories of biomarkers, depending on the substrate they represent or the method of harvesting. We will discuss about genetic biomarkers like microsatellite instability, KRAS, BRAF etc. Blood-based biomarkers available to monitor patients with colorectal cancer are represented by CEA and carbohydrate antigen 19-9 (CA19-9). CEA, a high molecular weight glycoprotein, is found in embryonic tissue and colorectal malignancies. We also present the stool markers. These markers are useful for screening patients at risk to develop colon cancer. The markers are also used to monitor the progression of the disease and the results of systemic therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
